Processa Pharmaceuticals
PCSA
PCSA
18 hedge funds and large institutions have $376K invested in Processa Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$66.7K | |
| 2 | +$35.5K | |
| 3 | +$34.4K | |
| 4 |
Two Sigma Investments
New York
|
+$8.26K |
| 5 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
+$5.58K |
Top Sellers
| 1 | -$107K | |
| 2 | -$49.1K | |
| 3 | -$13.6K | |
| 4 |
Millennium Management
New York
|
-$6.61K |
| 5 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
-$4.88K |